IMMUNOHEMATOLOGY - LECTINS - ANVISA Registration 10154450104
Access comprehensive regulatory information for IMMUNOHEMATOLOGY - LECTINS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10154450104 and manufactured by FRESENIUS HEMOCARE BRASIL LTDA.. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Oct 27, 2034.
This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including DOMINION BIOLOGICALS LIMITED, LORNE LABORATORIES LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10154450104
25351030524200416
49601107000184
Company Information
Dates and Status
Oct 27, 2004
27/10/2034
09/18/2025 19:00:01
IMUNOHEMATOLOGIA - LECTINAS
Anti-A1 Lectin
Not specified
80134860248
Jul 10, 2017
IMUNOHEMATOLOGIA - LECTINAS
Anti-A1 Lectin
MEDION GRIFOLS DIAGNOSTICS AG
80134860248
Jul 10, 2017
IMUNOHEMATOLOGIA - LECTINAS
Anti-A1 Lectin (Dolichos Biflorus)
Not specified
10077090141
Mar 01, 2017
IMUNOHEMATOLOGIA - LECTINAS
Anti-A1 Lectin (Dolichos Biflorus)
DOMINION BIOLOGICALS LIMITED
10077090141
Mar 01, 2017
IMUNOHEMATOLOGIA - LECTINAS
Famรญlia de Lectinas
LORNE LABORATORIES LTD
80115310132
Nov 30, 2009

